Related Experiment Videos

Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB

P W Yu1, B C Huang, M Shen

  • 1Rigel, Inc. 240 East Grand Ave, South San Francisco, California 94080, USA.

Insights

Researchers identified RIP3, a novel kinase involved in the tumor necrosis factor (TNF) signaling pathway. RIP3 acts as an intermediary in TNF-induced apoptosis, influencing caspase activation but not NF-kappaB activation.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Immunology

Background:

  • Tumor necrosis factor receptor 1 (TNFR1) and Fas receptor initiate signaling cascades via adaptor proteins.
  • Understanding TNF signaling pathway components is crucial for deciphering cellular responses.

Purpose of the Study:

  • To identify novel proteins interacting with the TNF signaling pathway.
  • To characterize the function of a newly identified kinase, RIP3.

Main Methods:

  • Yeast two-hybrid interaction screen using RIP as bait.
  • Co-immunoprecipitation assays in mammalian cells.
  • Functional assays involving NF-kappaB activation and apoptosis induction.

Main Results:

  • A novel kinase, RIP3, was identified and shares homology with RIP and RIP2.
  • RIP3 interacts with RIP, TRAF2, and TNFR1 in mammalian cells.
  • The carboxy-terminal domain of RIP3 activates NF-kappaB and induces apoptosis, independent of its kinase domain.
  • Dominant-negative RIP3 mutant inhibits TNFalpha-induced caspase activation but not NF-kappaB activation.

Conclusions:

  • RIP3 functions as an intermediary in TNFalpha-induced apoptosis.
  • RIP3 plays a role in regulating caspase activation during TNF signaling.

Related Concept Videos